Literature DB >> 32484284

Applications of CRISPR technologies in transplantation.

Cem Kuscu1, Canan Kuscu1, Amandeep Bajwa1, James D Eason1, Daniel Maluf1, Valeria R Mas1.   

Abstract

In transplantation, the ever-increasing number of an organ's demand and long-term graft dysfunction constitute some of the major problems. Therefore, alternative solutions to increase the quantity and quality of the organ supply for transplantation are desired. On this subject, revolutionary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) technology holds enormous potential for the scientific community with its expanding toolbox. In this minireview, we summarize the history and mechanism of CRISPR/Cas9 systems and explore its potential applications in cellular- and organ-level transplantation. The last part of this review includes future opportunities as well as the challenges in the transplantation field.
© 2020 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  animal models: porcine; basic (laboratory) research/science; genomics; immunosuppression/immune modulation; molecular biology; tolerance: chimerism; translational research/science; xenoantigen; xenotransplantation

Mesh:

Year:  2020        PMID: 32484284      PMCID: PMC8109183          DOI: 10.1111/ajt.16095

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  86 in total

1.  CRISPR-STOP: gene silencing through base-editing-induced nonsense mutations.

Authors:  Cem Kuscu; Mahmut Parlak; Turan Tufan; Jiekun Yang; Karol Szlachta; Xiaolong Wei; Rashad Mammadov; Mazhar Adli
Journal:  Nat Methods       Date:  2017-06-05       Impact factor: 28.547

2.  Advancing Mesenchymal Stem Cell Therapy with CRISPR/Cas9 for Clinical Trial Studies.

Authors:  Ali Golchin; Forough Shams; Farshid Karami
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

3.  In situ repurposing of dendritic cells with CRISPR/Cas9-based nanomedicine to induce transplant tolerance.

Authors:  Yue Zhang; Song Shen; Gui Zhao; Cong-Fei Xu; Hou-Bing Zhang; Ying-Li Luo; Zhi-Ting Cao; Jia Shi; Zhi-Bin Zhao; Zhe-Xiong Lian; Jun Wang
Journal:  Biomaterials       Date:  2019-06-24       Impact factor: 12.479

4.  Breaking the code of DNA binding specificity of TAL-type III effectors.

Authors:  Jens Boch; Heidi Scholze; Sebastian Schornack; Angelika Landgraf; Simone Hahn; Sabine Kay; Thomas Lahaye; Anja Nickstadt; Ulla Bonas
Journal:  Science       Date:  2009-12-11       Impact factor: 47.728

5.  Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis.

Authors:  Zhonggang Hou; Yan Zhang; Nicholas E Propson; Sara E Howden; Li-Fang Chu; Erik J Sontheimer; James A Thomson
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-12       Impact factor: 11.205

6.  In vivo genome editing using Staphylococcus aureus Cas9.

Authors:  F Ann Ran; Le Cong; Winston X Yan; David A Scott; Jonathan S Gootenberg; Andrea J Kriz; Bernd Zetsche; Ophir Shalem; Xuebing Wu; Kira S Makarova; Eugene V Koonin; Phillip A Sharp; Feng Zhang
Journal:  Nature       Date:  2015-04-01       Impact factor: 49.962

7.  Manipulation of nuclear architecture through CRISPR-mediated chromosomal looping.

Authors:  Stefanie L Morgan; Natasha C Mariano; Abel Bermudez; Nicole L Arruda; Fangting Wu; Yunhai Luo; Gautam Shankar; Lin Jia; Huiling Chen; Ji-Fan Hu; Andrew R Hoffman; Chiao-Chain Huang; Sharon J Pitteri; Kevin C Wang
Journal:  Nat Commun       Date:  2017-07-13       Impact factor: 14.919

8.  Multifunctional CRISPR-Cas9 with engineered immunosilenced human T cell epitopes.

Authors:  Shayesteh R Ferdosi; Radwa Ewaisha; Farzaneh Moghadam; Sri Krishna; Jin G Park; Mo R Ebrahimkhani; Samira Kiani; Karen S Anderson
Journal:  Nat Commun       Date:  2019-04-23       Impact factor: 14.919

9.  CRISPR RNA-guided activation of endogenous human genes.

Authors:  Morgan L Maeder; Samantha J Linder; Vincent M Cascio; Yanfang Fu; Quan H Ho; J Keith Joung
Journal:  Nat Methods       Date:  2013-07-25       Impact factor: 28.547

10.  High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects.

Authors:  Benjamin P Kleinstiver; Vikram Pattanayak; Michelle S Prew; Shengdar Q Tsai; Nhu T Nguyen; Zongli Zheng; J Keith Joung
Journal:  Nature       Date:  2016-01-06       Impact factor: 49.962

View more
  1 in total

1.  Editorial: Ex vivo Liver Machine Perfusion.

Authors:  Arash Nickkholgh; Daniel G Maluf; Peter Schemmer
Journal:  Front Surg       Date:  2022-03-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.